ALYSSA ROBINSON: Open Payments
NPI 1891060760 · BROWNSBURG, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$862 in 42 payments from 16 companies in 2025. Trend: 2023 $944 · 2024 $1,084 · 2025 $862
Food & beverage: $862
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $144 |
| Novartis Pharmaceuticals Corporation | 4 | $99 |
| Novo Nordisk Inc | 5 | $94 |
| Lilly USA, LLC | 5 | $85 |
| ABBVIE INC. | 5 | $79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $59 |
| Exact Sciences Corporation | 3 | $54 |
| Phathom Pharmaceuticals, Inc. | 2 | $46 |
| PFIZER INC. | 2 | $37 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
Products named: BREZTRI, LEQVIO, MOUNJARO, JARDIANCE, Cologuard Collection Kit, VOQUEZNA, Kerendia, VRAYLAR.
Industry payments across IN — which companies pay providers there.
